Group of research subjects receiving same treatment.
1Results: A total of 82 patients were included in the study cohort.
2Results: A total of 22 pregnancies were recorded among the study cohort.
3Methods: The eligible study cohort was identified through the Rochester Medical Index database.
4Patients and methods: The study cohort comprised 279 patients with cytology-proven LN-positivity before NAC.
5Findings: 70 patients were included in the final study cohort.
6We evaluated 19 candidate risk factors in the study cohort.
7Overt anemia developed in close to 10% of the study cohort.
8The study cohort was divided into 2 groups, those with and without concomitant pulmonary resection.
9CONCLUSIONS: For patients … RESULTS: A total of 82 patients were included in the study cohort.
10The study cohort included 77 patients who fulfilled at least one of the revised Bethesda guidelines.
11The study cohort was formed by the 27 patients with low-ADC lesions and no corresponding enhancement.
12The detailed study cohort consisted of 112 patients.
13Results: The inpatient study cohort included 391,958 patients who experienced 685,753 hospitalizations.
14Results: Our study cohort comprised of 380,981 patients treated at 178 HRRs.
15Therefore we divided our study cohort according to the median blood pressure reduction in response to irbesartan.
16The study cohort was comprised of the participants of the Lithuanian High Cardiovascular Risk primary prevention program.
Aquesta col·locació està formada per: